(4S)-3,4-二氢-2H-1-苯并吡喃-4-胺盐酸盐 | 1035093-81-2

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡喃类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 中文名称: (4S)-3,4-二氢-2H-1-苯并吡喃-4-胺盐酸盐
• 英文名称: (S)-chroman-4-amine hydrochloride
• 英文别名: (4S)-chroman-4-amine hydrochloride；(4S)-3,4-dihydro-2H-chromen-4-amine;hydrochloride
• CAS: 1035093-81-2
• 化学式: C₉H₁₁NO*ClH
• mdl: MFCD08752571
• 分子量: 185.653
• InChiKey: BVMKYKMJUZEGBU-QRPNPIFTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.89
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  35.2
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: (S)-Chroman-4-ylamine, HCl
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: (S)-Chroman-4-ylamine, HCl
CAS number: 1035093-81-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H12ClNO
Molecular weight: 185.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (4S)-3,4-二氢-2H-1-苯并吡喃-4-胺盐酸盐 、 (R)-2-(9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl)acetaldehyde 在 三乙酰氧基硼氢化钠 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 13.0h， 以32.1%的产率得到(S)-N-(2-((R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl)ethyl)chroman-4-amine
  参考文献：
  名称：

  OXA SPIRO DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF IN MEDICINES

  摘要：

  公开号：

  EP3354649B1
• 作为产物：
  描述：

  3,4-二氢-2H-苯并吡喃-4-胺 、 甲氧基乙酸甲酯 在 Novozym 435 盐酸 作用下， 以 甲基叔丁基醚 、 乙醇 、 二氯甲烷 为溶剂， 生成 2-methoxy-N-((R)-3,4-dihydro-2H-chromen-4-yl)acetamide 、 (4S)-3,4-二氢-2H-1-苯并吡喃-4-胺盐酸盐
  参考文献：
  名称：

  Amino-1,3,5-triazines N-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators

  摘要：

  氨基-1,3,5-三嗪经手性双环基团N-取代，其制备方法，组合物及其作为除草剂和植物生长调节剂的用途。该发明涉及化学式(I)或其盐的光学活性化合物：其中各符号如描述中定义，其制备方法，组合物及其作为除草剂或植物生长调节剂的用途。该发明还涉及描述中定义的化学式(III)、(V)和(XIII)的新中间体。

  公开号：

  US20040157739A1

文献信息

• ANTAGONISTS OF THE TRPV1 RECEPTOR AND USES THEREOF
  申请人：Bayburt Erol K.

  公开号：US20080153871A1

  公开（公告）日：2008-06-26

  The present application is directed to compounds that are TRPV1 antagonists and have formula (I) wherein variables Ar 1 , L 1 , R 1 , R 2 , R 3 , R 4 , R 5 , Y 1 , Y 2 , and Y 3 , are as defined in the description, which are useful for treating disorders caused by or exacerbated by vanilloid receptor activity.

  本申请涉及的化合物是TRPV1拮抗剂，其化学式为（I），其中变量Ar1，L1，R1，R2，R3，R4，R5，Y1，Y2和Y3如描述中所定义，对于治疗由辣椒素受体活性引起或加剧的疾病是有用的。
• [EN] NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS DE QUINOLÉINE-3-CARBOXAMIDE ANTHELMINTHIQUES
  申请人：BAYER ANIMAL HEALTH GMBH

  公开号：WO2018087036A1

  公开（公告）日：2018-05-17

  The present invention covers new quinoline compounds of general formula (I) in which A, R1, R2, R3, R4, R5, R6, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.

  本发明涵盖了一般式(I)中的新喹啉化合物，其中A、R1、R2、R3、R4、R5、R6和Q的定义如本文所述，制备所述化合物的方法，用于制备所述化合物的中间体化合物，包含所述化合物的药物组合物和组合物，以及利用所述化合物制造用于治疗、控制和/或预防疾病的药物组合物，特别是蠕虫感染，作为唯一药剂或与其他活性成分组合使用。
• [EN] QUINOLINE DERIVATIVES FOR TREATING INFECTIONS WITH HELMINTHS<br/>[FR] DÉRIVÉS DE QUINOLÉINE DESTINÉS AU TRAITEMENT D'INFECTIONS PAR DES HELMINTHES
  申请人：BAYER ANIMAL HEALTH GMBH

  公开号：WO2019025341A1

  公开（公告）日：2019-02-07

  The present invention covers quinoline compounds of general formula (I), in which A, R1, R2, R3, R4, R5, R6, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.

  本发明涵盖了通式（I）所示的喹啉化合物，其中A、R1、R2、R3、R4、R5、R6和Q的定义如本文所述，制备所述化合物的方法，用于制备所述化合物的中间体化合物，包含所述化合物的药物组合物和组合物，以及利用所述化合物制造用于治疗、控制和/或预防疾病的药物组合物，特别是蠕虫感染，作为单一药剂或与其他活性成分组合使用。
• [EN] BICYCLIC DERIVATIVES<br/>[FR] DÉRIVÉS BICYCLIQUES
  申请人：ELANCO TIERGESUNDHEIT AG

  公开号：WO2020131631A1

  公开（公告）日：2020-06-25

  The present invention provides compounds of formula (I): (I) which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.

  本发明提供了式(I)的化合物，这些化合物在温血动物中对内寄生虫，例如心丝虫，的控制中是有用的。
• [EN] PYRAZOLOPYRIMIDINE DERIVATIVES<br/>[FR] DÉRIVÉS DE PYRAZOLOPYRIMIDINE
  申请人：BAYER ANIMAL HEALTH GMBH

  公开号：WO2017178416A1

  公开（公告）日：2017-10-19

  The present invention covers Pyrazolopyrimidine compounds of general formula (I), in which n, o, X, Y, R, Q, R1, R2, R3 and R4 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.

  本发明涵盖了通式（I）中的吡唑吡啶化合物，其中n、o、X、Y、R、Q、R1、R2、R3和R4如本文所定义，制备上述化合物的方法，用于制备上述化合物的有用中间体化合物，包含上述化合物的药物组合物和药物组合物，以及利用上述化合物制造用于治疗、控制和/或预防疾病的药物组合物，特别是蠕虫感染，作为单一药剂或与其他活性成分组合使用。